Elderly patients with glioblastoma: The treatment challenge

Alba Fiorentino, Pasquale De Bonis, Silvia Chiesa, Mario Balducci, Vincenzo Fusco

Research output: Contribution to journalArticle

Abstract

The treatment for elderly patients affected by glioblastoma represents a challenge in neuro-oncology. The recent randomized trials (the NOA-8 and the NCBTSG trials) showed an advantage of temozolomide for patients with O6-methylguanine methyltransferase methylated tumors. To date, no randomized trials compared the standard treatment (radiochemotherapy) with other therapeutic approaches, due to the idea that elderly patients do not tolerate aggressive therapy. Nonetheless, with the increased lifespan and the better quality of life, the nihilism in the treatment of elderly with cancer is obsolete. Molecular (including O6-methylguanine methyltransferase) and clinical tools (including the geriatric evaluation) are needed for choosing the proper therapy for patients over 70.

Original languageEnglish
Pages (from-to)1099-1105
Number of pages7
JournalExpert Review of Neurotherapeutics
Volume13
Issue number10
DOIs
Publication statusPublished - 2013

Fingerprint

Glioblastoma
temozolomide
Methyltransferases
Therapeutics
Chemoradiotherapy
Geriatrics
Neoplasms
Quality of Life

Keywords

  • elderly patients
  • glioblastoma
  • radiochemotherapy
  • surgery
  • temozolomide

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology (medical)

Cite this

Elderly patients with glioblastoma : The treatment challenge. / Fiorentino, Alba; Bonis, Pasquale De; Chiesa, Silvia; Balducci, Mario; Fusco, Vincenzo.

In: Expert Review of Neurotherapeutics, Vol. 13, No. 10, 2013, p. 1099-1105.

Research output: Contribution to journalArticle

Fiorentino, Alba ; Bonis, Pasquale De ; Chiesa, Silvia ; Balducci, Mario ; Fusco, Vincenzo. / Elderly patients with glioblastoma : The treatment challenge. In: Expert Review of Neurotherapeutics. 2013 ; Vol. 13, No. 10. pp. 1099-1105.
@article{4d38ea62c20041e09c869a6158ec0616,
title = "Elderly patients with glioblastoma: The treatment challenge",
abstract = "The treatment for elderly patients affected by glioblastoma represents a challenge in neuro-oncology. The recent randomized trials (the NOA-8 and the NCBTSG trials) showed an advantage of temozolomide for patients with O6-methylguanine methyltransferase methylated tumors. To date, no randomized trials compared the standard treatment (radiochemotherapy) with other therapeutic approaches, due to the idea that elderly patients do not tolerate aggressive therapy. Nonetheless, with the increased lifespan and the better quality of life, the nihilism in the treatment of elderly with cancer is obsolete. Molecular (including O6-methylguanine methyltransferase) and clinical tools (including the geriatric evaluation) are needed for choosing the proper therapy for patients over 70.",
keywords = "elderly patients, glioblastoma, radiochemotherapy, surgery, temozolomide",
author = "Alba Fiorentino and Bonis, {Pasquale De} and Silvia Chiesa and Mario Balducci and Vincenzo Fusco",
year = "2013",
doi = "10.1586/14737175.2013.840419",
language = "English",
volume = "13",
pages = "1099--1105",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - Elderly patients with glioblastoma

T2 - The treatment challenge

AU - Fiorentino, Alba

AU - Bonis, Pasquale De

AU - Chiesa, Silvia

AU - Balducci, Mario

AU - Fusco, Vincenzo

PY - 2013

Y1 - 2013

N2 - The treatment for elderly patients affected by glioblastoma represents a challenge in neuro-oncology. The recent randomized trials (the NOA-8 and the NCBTSG trials) showed an advantage of temozolomide for patients with O6-methylguanine methyltransferase methylated tumors. To date, no randomized trials compared the standard treatment (radiochemotherapy) with other therapeutic approaches, due to the idea that elderly patients do not tolerate aggressive therapy. Nonetheless, with the increased lifespan and the better quality of life, the nihilism in the treatment of elderly with cancer is obsolete. Molecular (including O6-methylguanine methyltransferase) and clinical tools (including the geriatric evaluation) are needed for choosing the proper therapy for patients over 70.

AB - The treatment for elderly patients affected by glioblastoma represents a challenge in neuro-oncology. The recent randomized trials (the NOA-8 and the NCBTSG trials) showed an advantage of temozolomide for patients with O6-methylguanine methyltransferase methylated tumors. To date, no randomized trials compared the standard treatment (radiochemotherapy) with other therapeutic approaches, due to the idea that elderly patients do not tolerate aggressive therapy. Nonetheless, with the increased lifespan and the better quality of life, the nihilism in the treatment of elderly with cancer is obsolete. Molecular (including O6-methylguanine methyltransferase) and clinical tools (including the geriatric evaluation) are needed for choosing the proper therapy for patients over 70.

KW - elderly patients

KW - glioblastoma

KW - radiochemotherapy

KW - surgery

KW - temozolomide

UR - http://www.scopus.com/inward/record.url?scp=84886876599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886876599&partnerID=8YFLogxK

U2 - 10.1586/14737175.2013.840419

DO - 10.1586/14737175.2013.840419

M3 - Article

C2 - 24117272

AN - SCOPUS:84886876599

VL - 13

SP - 1099

EP - 1105

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 10

ER -